Literature DB >> 8549432

Motor evoked potentials by magnetic stimulation in hereditary and sporadic ataxia.

M Mondelli1, A Rossi, C Scarpini, G C Guazzi.   

Abstract

We report the study of motor evoked potentials by magnetic stimulation in 26 subjects with hereditary or sporadic ataxia. The subjects included 15 cases of late onset cerebellar ataxia (12 classified as olivopontocerebellar atrophy (OPCA), 3 as spinocerebellar atrophy (SCA)) and 11 cases of early onset cerebellar ataxia (4 Friedreich's ataxia (FA) and 7 unclassifiable in Friedreich's ataxia (NFA)). All subjects with FA and SCA had delayed central motor conduction times, more accentuated in corticospinal tracts directed to lumbar motoneurons. A similar but less marked slowing was observed in about half of the subjects with OPCA and NFA. In the last two groups the anomalies are more frequent in hereditary than in sporadic forms.

Entities:  

Mesh:

Year:  1995        PMID: 8549432

Source DB:  PubMed          Journal:  Electromyogr Clin Neurophysiol        ISSN: 0301-150X


  4 in total

Review 1.  Diagnosis and treatment of Friedreich ataxia: a European perspective.

Authors:  Jörg B Schulz; Sylvia Boesch; Katrin Bürk; Alexandra Dürr; Paola Giunti; Caterina Mariotti; Francoise Pousset; Ludger Schöls; Pierre Vankan; Massimo Pandolfo
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

2.  Sporadic adult onset ataxia of unknown etiology : a clinical, electrophysiological and imaging study.

Authors:  M Abele; M Minnerop; H Urbach; K Specht; T Klockgether
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

Review 3.  Transcranial magnetic stimulation in child neurology: current and future directions.

Authors:  Richard E Frye; Alexander Rotenberg; Molliann Ousley; Alvaro Pascual-Leone
Journal:  J Child Neurol       Date:  2007-12-03       Impact factor: 1.987

4.  Central Nervous System Therapeutic Targets in Friedreich Ataxia.

Authors:  Ian H Harding; David R Lynch; Arnulf H Koeppen; Massimo Pandolfo
Journal:  Hum Gene Ther       Date:  2020-12       Impact factor: 5.695

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.